Close



May 22, 2020 09:29AM
Dec 16, 2019 07:00AM
Dec 16, 2019 06:47AM
Dec 13, 2019 09:02AM
Dec 3, 2019 06:46AM
Dec 2, 2019 09:45AM
Dec 2, 2019 06:04AM Amarin Corp. (AMRN) Announces EMA to Validate Marketing Authotization Application for Icosapent Ethyl (Vascepa)
Dec 2, 2019 06:00AM
Dec 2, 2019 06:00AM
Nov 22, 2019 01:26PM
Nov 20, 2019 09:16AM
Nov 19, 2019 05:57PM
Nov 15, 2019 09:23AM
Nov 14, 2019 05:49PM Cantor Fitzgerald Expects Shares of Amarin (AMRN) to Rise After 16-0 Favorable FDA Adcom Vote
Nov 14, 2019 05:35PM
Nov 14, 2019 05:34PM
Nov 14, 2019 05:34PM
Nov 14, 2019 06:59AM
Nov 14, 2019 06:59AM
Nov 14, 2019 06:59AM
Nov 6, 2019 06:13AM Amarin Corporation (AMRN) Could Have 20% Upside Over the Next Week - Citi
Nov 5, 2019 05:50AM
Nov 5, 2019 05:00AM
Nov 5, 2019 05:00AM
Nov 4, 2019 06:00AM
Nov 4, 2019 06:00AM
Oct 17, 2019 09:51AM
Oct 17, 2019 09:49AM Independent Drug-Pricing Assessment Finds Vascepa® (icosapent ethyl) Cost-Effective as an Adjunct to Statins in Treating Patients at High Risk of Cardiovascular Events, such as Heart Attack, Stroke a
Oct 17, 2019 09:48AM
Sep 16, 2019 10:32AM
Sep 16, 2019 06:23AM
Sep 16, 2019 06:00AM
Sep 16, 2019 06:00AM
Sep 12, 2019 10:00AM
Sep 12, 2019 06:53AM Amarin Corp. (AMRN) Said FDA Confirms December 28 PDUFA Date for REDUCE-IT sNDA
Aug 14, 2019 07:11AM
Aug 9, 2019 09:12AM
Aug 8, 2019 04:31PM
Aug 8, 2019 04:30PM
Aug 8, 2019 04:30PM
Aug 1, 2019 06:35AM
Jul 31, 2019 05:44AM Amarin Corp. (AMRN) Tops Q2 EPS by 4c, Revenues Beat
Jul 31, 2019 05:00AM
Jul 31, 2019 05:00AM
Jul 3, 2019 08:09AM
Jul 2, 2019 11:59AM
Jul 2, 2019 06:07AM
Jul 2, 2019 06:00AM
Jul 2, 2019 06:00AM Amarin Provides Mid-2019 Update, Including Commercialization Plans for Vascepa® and Updates Full Year 2019 Revenue Guidance
Jun 20, 2019 10:09AM

11,821 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All